Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by skyhigh123on Mar 26, 2018 7:01pm

288 Views

Post# 27784881

FDA PDUFA 90 day extension ( 3 months)

After reading a few FDA news releases regarding the 90 day extension it appears that the FDA contacts the company 30 days before the original assigned date . This like all things regarding the FDA is not written in stone
sky

Bullboard Posts

Three high-conviction small-cap stocks across the risk spectrum